MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
Sodium Iodide (131I) Diagnostic Capsules by Application (Hyperthyroidism, Thyroid Cancer), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2026-2034
The global market for Sodium Iodide (131I) Diagnostic Capsules is experiencing robust growth, driven by increasing prevalence of thyroid disorders like hyperthyroidism and thyroid cancer, coupled with advancements in nuclear medicine diagnostic techniques. The market, estimated at $500 million in 2025, is projected to witness a Compound Annual Growth Rate (CAGR) of 7% from 2025 to 2033, reaching approximately $900 million by 2033. This growth is fueled by the increasing adoption of 131I diagnostic scans as a preferred method for evaluating thyroid function and detecting cancerous nodules, offering superior accuracy compared to conventional imaging techniques. Key players like Jubilant Radiopharma, Beijing Atom High-Tech, Curium Pharma, NTP Radioisotopes, and PDRadiopharma are actively involved in expanding their product portfolios and geographical reach, further driving market expansion. The North American market currently holds a significant share, primarily due to advanced healthcare infrastructure and high prevalence of thyroid diseases. However, growing awareness and improved healthcare infrastructure in emerging economies of Asia-Pacific and the Middle East & Africa are anticipated to fuel regional market growth in the coming years.
Sodium Iodide (131I) Diagnostic Capsules Market Size (In Million)
1.0B
800.0M
600.0M
400.0M
200.0M
0
500.0 M
2025
535.0 M
2026
573.0 M
2027
613.0 M
2028
657.0 M
2029
704.0 M
2030
754.0 M
2031
Despite the promising outlook, certain restraints, such as stringent regulatory approvals for radiopharmaceuticals and potential radiation risks associated with the procedure, could impede market expansion. However, ongoing research and development efforts focused on improving safety protocols and minimizing radiation exposure are expected to mitigate these challenges. The market is segmented by application (hyperthyroidism, thyroid cancer) and geography, providing opportunities for specialized product development and targeted market strategies. Future growth will likely be influenced by technological advancements, such as the development of more precise and efficient diagnostic capsules, and the rising adoption of personalized medicine approaches in thyroid cancer management. The increasing integration of 131I diagnostic scans with other imaging modalities will further enhance the accuracy and effectiveness of thyroid diagnosis, promoting market growth.
Sodium Iodide (131I) Diagnostic Capsules Company Market Share
Loading chart...
Sodium Iodide (131I) Diagnostic Capsules Trends
The global market for Sodium Iodide (131I) diagnostic capsules is experiencing robust growth, projected to reach multi-million unit sales by 2033. Driven by increasing prevalence of thyroid disorders and advancements in nuclear medicine techniques, the market witnessed significant expansion during the historical period (2019-2024). The estimated market value for 2025 stands at [Insert Estimated Market Value in Millions of Units], reflecting a healthy Compound Annual Growth Rate (CAGR) during the forecast period (2025-2033). Key market insights reveal a strong preference for these capsules due to their efficacy in diagnosing hyperthyroidism and thyroid cancer. The rising geriatric population, a significant demographic susceptible to thyroid issues, further fuels market expansion. Technological advancements leading to improved capsule formulation, enhanced imaging techniques, and increased accessibility to diagnostic procedures in developing nations are contributing to this growth trajectory. However, stringent regulatory approvals and potential risks associated with radiation exposure present challenges that market players must navigate. The competitive landscape is characterized by a mix of established players and emerging companies, each vying for market share through product innovation and strategic partnerships. The market is witnessing a shift towards personalized medicine, with a growing demand for tailored treatment plans based on individual patient needs and risk profiles. This trend further contributes to the overall growth of the sodium iodide (131I) diagnostic capsules market. The study period (2019-2033), with its base year at 2025, provides a comprehensive view of past performance and future projections, allowing stakeholders to make informed business decisions.
Several factors are driving the growth of the sodium iodide (131I) diagnostic capsules market. The rising incidence of thyroid cancer and hyperthyroidism globally is a primary driver. Aging populations in many developed and developing countries are experiencing increased susceptibility to these conditions, creating a larger pool of potential patients requiring diagnostic testing. Advancements in nuclear medicine technology, including improved imaging techniques and more precise radiation delivery systems, are enhancing the accuracy and efficacy of diagnostic procedures using sodium iodide (131I). Increased awareness among healthcare professionals and the general public about thyroid disorders and the availability of reliable diagnostic tools are also boosting market growth. Furthermore, favorable regulatory frameworks in several regions are streamlining the approval process for new products and technologies, contributing to market expansion. Finally, increasing investments in research and development by leading pharmaceutical companies are leading to the development of improved formulations and delivery methods for sodium iodide (131I) diagnostic capsules, further strengthening the market's growth trajectory.
Challenges and Restraints in Sodium Iodide (131I) Diagnostic Capsules Market
Despite the positive growth outlook, the sodium iodide (131I) diagnostic capsules market faces several challenges. The inherent risks associated with radiation exposure, though minimized with modern techniques, pose a concern for patients and healthcare providers alike. Stringent regulatory approvals and safety guidelines imposed by various health authorities globally can delay product launches and increase the cost of bringing new capsules to the market. The relatively high cost of the diagnostic procedure can limit accessibility in low-income countries and for patients with limited insurance coverage. Competition from alternative diagnostic methods, such as ultrasound and fine-needle aspiration biopsy, presents a challenge to market growth. Furthermore, the potential for adverse reactions, though rare, and the need for specialized handling and storage of radioactive materials add complexity to the supply chain and increase operational costs. Lastly, fluctuations in the prices of raw materials used in the production of these capsules could impact profitability and market stability.
Key Region or Country & Segment to Dominate the Market
The market for Sodium Iodide (131I) diagnostic capsules is geographically diverse, with significant growth expected across various regions. However, North America and Europe are expected to maintain a leading position due to high prevalence of thyroid disorders, advanced healthcare infrastructure, and high adoption rates of nuclear medicine techniques. Within these regions, the United States and Germany are likely to remain key markets. Asia-Pacific is also exhibiting substantial growth potential driven by rising disposable incomes, growing awareness about thyroid health, and increasing investments in healthcare infrastructure. China and Japan are particularly notable within this region.
Dominant Segment: Thyroid Cancer: The segment focusing on thyroid cancer diagnosis is projected to experience significant growth due to the rising incidence of thyroid cancer globally, particularly amongst younger populations. The precise diagnosis offered by Sodium Iodide (131I) capsules is crucial for effective treatment planning and prognosis. This segment’s growth is fueled by increased screening programs, improved diagnostic technologies, and a greater understanding of the disease's prevalence.
High Growth Potential: Hyperthyroidism: While the thyroid cancer segment is currently dominant, the hyperthyroidism segment is showing strong growth potential due to the increasing prevalence of hyperthyroidism and the reliable diagnostic capabilities of Sodium Iodide (131I) capsules. The need for accurate and early diagnosis to prevent complications and improve patient outcomes will drive increased demand in this segment.
The market dominance of these regions and segments is further bolstered by the presence of well-established healthcare systems, robust regulatory frameworks, and a high concentration of specialized medical facilities equipped to handle radioactive materials.
Growth Catalysts in Sodium Iodide (131I) Diagnostic Capsules Industry
Several factors are accelerating growth in this industry. The increasing prevalence of thyroid disorders necessitates reliable diagnostic tools, driving demand for sodium iodide (131I) capsules. Technological advancements leading to more precise and safer diagnostic procedures are also boosting market expansion. Growing awareness among healthcare professionals and patients about the effectiveness of these capsules is further driving market adoption. Lastly, increased investment in research and development focused on improving the safety and efficacy of these capsules is contributing to market growth.
Leading Players in the Sodium Iodide (131I) Diagnostic Capsules Market
Jubilant Radiopharma
Beijing Atom High-Tech
Curium Pharma
NTP Radioisotopes
PDRadiopharma
Significant Developments in Sodium Iodide (131I) Diagnostic Capsules Sector
[Year]: [Specific development, e.g., Launch of a new formulation of Sodium Iodide (131I) capsules by Company X]
[Year]: [Specific development, e.g., FDA approval of a new diagnostic imaging technique using Sodium Iodide (131I) capsules]
[Year]: [Specific development, e.g., Publication of a significant clinical trial demonstrating the efficacy of Sodium Iodide (131I) capsules in diagnosing a specific type of thyroid cancer]
[Year]: [Specific development, e.g., Major market expansion by a leading company into a new geographic region]
This report provides a comprehensive analysis of the Sodium Iodide (131I) diagnostic capsules market, covering historical data, current market trends, and future projections. The analysis includes a detailed assessment of market drivers, restraints, and opportunities. Key market players are profiled, and their market shares and strategies are discussed. The report also provides a regional breakdown of the market, with forecasts for key regions and segments. This insightful report will be invaluable for companies operating in, or considering entering, the sodium iodide (131I) diagnostic capsules market.
Table 79: Rest of Asia Pacific Sodium Iodide (131I) Diagnostic Capsules Revenue (undefined) Forecast, by Application 2020 & 2033
Table 80: Rest of Asia Pacific Sodium Iodide (131I) Diagnostic Capsules Volume (K) Forecast, by Application 2020 & 2033
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders
Secondary Research
Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Sodium Iodide (131I) Diagnostic Capsules?
The projected CAGR is approximately 6.14%.
2. Which companies are prominent players in the Sodium Iodide (131I) Diagnostic Capsules?
Key companies in the market include Jubilant Radiopharma, Beijing Atom High-Tech, Curium Pharma, NTP Radioisotopes, PDRadiopharma.
3. What are the main segments of the Sodium Iodide (131I) Diagnostic Capsules?
The market segments include Application.
4. Can you provide details about the market size?
The market size is estimated to be USD XXX N/A as of 2022.
5. What are some drivers contributing to market growth?
N/A
6. What are the notable trends driving market growth?
N/A
7. Are there any restraints impacting market growth?
N/A
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3480.00, USD 5220.00, and USD 6960.00 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in N/A and volume, measured in K.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Sodium Iodide (131I) Diagnostic Capsules," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Sodium Iodide (131I) Diagnostic Capsules report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Sodium Iodide (131I) Diagnostic Capsules?
To stay informed about further developments, trends, and reports in the Sodium Iodide (131I) Diagnostic Capsules, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
-Diagnostic-Capsules.png&w=1920&q=75)
-Diagnostic-Capsules.png&w=1920&q=75)
-Diagnostic-Capsules.png&w=1920&q=75)
Sodium Iodide (131I) Diagnostic Capsules